About the Company:
Cian Healthcare Ltd is a WHO-GMP & ISO -9001:2015 certified transnational manufacturing Company with wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals and Food supplement products.
Company develops, manufactures and commercializes pharmaceutical products under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals.
Company works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies.
Company manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet.
Cian Healthcare has special licence for manufacturing veterinary products for client like SAVAvet and Venky’s.
Cian has developed more than 1,000 formulations and 2000 brands for domestic market under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals.
Company’s Business Model:
- Mr. Suraj Zanwar (Designation: Managing Director)
- Mr. Pankaj Zanwar (Designation: Non-Executive Director)
Objectives of the Issue:
- Upgradation of existing plant i.e. Unit 1 situated at Roorkee, Uttarakhand, India
- Margin Money for Setting up of manufacturing facility i.e. Unit 2 situated at Roorkee, Uttarakhand, India
- Enhancement of our Company’s brand through advertising and other brand-building activities
- Long term working capital requirements
- Acquisitions and other strategic initiatives
- General corporate purposes.
Competitive Strengths for the Company:
Established Manufacturing Facility. (Roorkee – I & Roorkee II)
Cian’s centralized manufacturing facility is situated at Roorkee. The manufacturing plant Roorkee – I consist of total built up area of 50,000 Sq. Ft. with WHO-GMP 9001: 2015 approval and planning to upgrade as per the New GMP standards.
To meet the increasing business need Company is in the process of setting of one more manufacturing unit that is Roorkee – II, which is adjacent to the Roorkee – I. The area of new facilities of Roorkee – II will be approximately 40,000 Sq. Ft.
Company has extended the business operations up to 29 countries like Myanmar, Sri Lanka, Turkmenistan, Tajikistan and Kenya.
Cial Healthcare has already registered 353 products in International market and applied for more than 585 products for registration / approval in international market.
Diversified Business Portfolio:
Cian has a diversified business portfolio and is not dependent on any specific segement. Company also brought in 24% of their total revenue from tender business in Financial year 2017-18.
Company also supplies to Central Govt, State Govt and International Govt Tenders. The tenders are from Haryana, Rajasthan, Andhra Pradesh, Tamil Nadu, Chhattisgarh and DHS Maharashtra.
Cian Healthcare has also supplied to renowned institutes and PSU’s like HLL, Mumbai Port Trust, BARC, JIPMER (Pondicherry).
Pradhan Mantri Jan Aaushadhi Pariyojana Scheme:
Cian Healthcare has have been an active supplier for Pradhan Mantri Jan Aaushadhi Pariyojana Scheme (JAN Aushadi Abhiyan) – BPPI where medicines are provided to Indian Citizen at Subsidized a rate through their more than 3000 outlets.
Company has received orders worth Rs.132.00 Crore order from BPPI and successfully supplied Rs.0.12 crores out of same.
Roorkee Plant Expansion:
Under Roorkee-II Expansion plan, Company is doing expansions of manufacturing capacities of Tablets, Capsules, Ayurvedic tablet, Ayurvedic Capsules, Ayurvedic Syrup, Cosmetics – Creams & Lotions, Soaps, Protein Powder, and Effervescent Tablets.
With this expansion, Company’s Tablet capacity will increase by 35 Cr Tablets, 5 Cr Capsules, Syrup by 15 Lacs bottles and Cosmetics by 40 Lacs tubes per month.
Financials of the Company:
|(in Crores)||FY 16||FY 17||FY 18||30th Sept 18|
Valuation of Peer Group Companies:
|Company Name||Face Value||EPS||PE Ratio||RoNW||NAV|
|Cian Healthcare Ltd||10||2.31||28.13||22.56%||10.22|
|Deccan Healthcare Ltd||10||9.75||10.25||6.62%||27.02|
|Zota Healthcare Ltd||10||4.23||62.07||10.42%||3.98|
|Sakar Healthcare Ltd||10||2.55||21.96||8.15%||3.83|
|Jenburkt Pharmaceuticals Ltd||10||37.50||12.27||28.10%||133.48|
|Issue Opens on||2nd May 2019|
|Issue Closes on:.||15th May 2019|
|Issue Price||Rs.59 – 65|
|Issue Size||Rs.40.4 cr|
|Market Cap||Rs.151.8 cr|
|Listing at||BSE SME|
|Equity Shares Offered (Fresh)||62,16,000|
|Equity Shares Prior to the Issue||1,71,44,764|
|Equity Shares after the Issue||2,33,60,764|
IPO Valuation Parameters:
|Earnings Per Share (EPS)||Price To Earnings ratio (PE)||Return on Net Worth (RoNW)||Net Asset Value (NAV)|
|Check IPO Allotment Status:|
Bigshare Website (Click on the below Link)
|Company Contact Info:|
|Cian Healthcare Limited
1St Floor, Premdeep Building,
Above Latur Urban Co-op Bank Ltd,
Lulla Nagar Chowk, Camp-Kondhwa Road,
Pune – 411 040, Maharashtra, India.
Tel No: 020-41471234 / 265
|IPO Registrar Info:|
|BIGSHARE SERVICES PRIVATE LIMITED
1st Floor, Bharat Tin Works Building,
Opp. Vasant Oasis, Makwana Road, Marol,
Andheri East, Mumbai-400 059, India.
Tel No.: +91 22 62638200
Fax No.: +91 22 62638299
|Lead Manager to the Issue:|
|FEDEX SECURITIES PRIVATE LIMITED
305, Enterprise Centre, Nehru Road,
Vile Parle (East), Mumbai 400099, Maharashtra, India.
Tel No.: +9181049 85249
Fax No.: 022 2618 6966